IRIS Accounts Production v24.3.0.553 09950456 director 1.2.23 31.1.24 31.1.24 false true false false false true false Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh099504562023-01-31099504562024-01-31099504562023-02-012024-01-31099504562022-01-31099504562022-02-012023-01-31099504562023-01-3109950456ns15:EnglandWales2023-02-012024-01-3109950456ns14:PoundSterling2023-02-012024-01-3109950456ns10:Director12023-02-012024-01-3109950456ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3109950456ns10:SmallEntities2023-02-012024-01-3109950456ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3109950456ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3109950456ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3109950456ns10:FullAccounts2023-02-012024-01-310995045612023-02-012024-01-3109950456ns10:OrdinaryShareClass12023-02-012024-01-3109950456ns5:CurrentFinancialInstruments2024-01-3109950456ns5:CurrentFinancialInstruments2023-01-3109950456ns5:Non-currentFinancialInstruments2024-01-3109950456ns5:Non-currentFinancialInstruments2023-01-3109950456ns5:ShareCapital2024-01-3109950456ns5:ShareCapital2023-01-3109950456ns5:RetainedEarningsAccumulatedLosses2024-01-3109950456ns5:RetainedEarningsAccumulatedLosses2023-01-3109950456ns10:RegisteredOffice2023-02-012024-01-3109950456ns5:NetGoodwill2023-02-012024-01-3109950456ns5:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3109950456ns5:NetGoodwill2023-01-3109950456ns5:NetGoodwill2024-01-3109950456ns5:NetGoodwill2023-01-3109950456ns5:PlantMachinery2023-01-3109950456ns5:PlantMachinery2023-02-012024-01-3109950456ns5:PlantMachinery2024-01-3109950456ns5:PlantMachinery2023-01-3109950456ns5:WithinOneYearns5:CurrentFinancialInstruments2024-01-3109950456ns5:WithinOneYearns5:CurrentFinancialInstruments2023-01-3109950456ns5:Secured2024-01-3109950456ns5:Secured2023-01-3109950456ns10:OrdinaryShareClass12024-01-31
REGISTERED NUMBER: 09950456 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2024

for

Lillibet Healthcare Limited

Lillibet Healthcare Limited (Registered number: 09950456)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


Lillibet Healthcare Limited (Registered number: 09950456)

Balance Sheet
31 January 2024

31.1.24 31.1.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 79,369 112,212
Tangible assets 5 33,751 45,001
113,120 157,213

CURRENT ASSETS
Stocks 5,350 5,350
Debtors 6 258,280 269,047
Cash at bank and in hand 988 3,963
264,618 278,360
CREDITORS
Amounts falling due within one year 7 226,188 263,211
NET CURRENT ASSETS 38,430 15,149
TOTAL ASSETS LESS CURRENT
LIABILITIES

151,550

172,362

CREDITORS
Amounts falling due after more than one
year

8

-

(5,788

)

PROVISIONS FOR LIABILITIES (8,438 ) (3,750 )
NET ASSETS 143,112 162,824

CAPITAL AND RESERVES
Called up share capital 11 100 100
Retained earnings 143,012 162,724
SHAREHOLDERS' FUNDS 143,112 162,824

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Lillibet Healthcare Limited (Registered number: 09950456)

Balance Sheet - continued
31 January 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 October 2024 and were signed by:





Dr S Krishnankutty - Director


Lillibet Healthcare Limited (Registered number: 09950456)

Notes to the Financial Statements
for the Year Ended 31 January 2024

1. STATUTORY INFORMATION

Lillibet Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 09950456

Registered office: 4 Gardener Place
Biddenham
Bedford
MK40 4QU

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
In the application of the company's accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Lillibet Healthcare Limited (Registered number: 09950456)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery25% reducing balance method

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Lillibet Healthcare Limited (Registered number: 09950456)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Lillibet Healthcare Limited (Registered number: 09950456)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 34 (2023 - 32 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 February 2023
and 31 January 2024 328,428
AMORTISATION
At 1 February 2023 216,216
Charge for year 32,843
At 31 January 2024 249,059
NET BOOK VALUE
At 31 January 2024 79,369
At 31 January 2023 112,212

Lillibet Healthcare Limited (Registered number: 09950456)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 February 2023
and 31 January 2024 103,758
DEPRECIATION
At 1 February 2023 58,757
Charge for year 11,250
At 31 January 2024 70,007
NET BOOK VALUE
At 31 January 2024 33,751
At 31 January 2023 45,001

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Trade debtors 111,661 55,216
Other debtors 146,619 213,831
258,280 269,047

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Bank loans and overdrafts 12,712 9,324
Trade creditors 7,703 6,163
Taxation and social security 47,424 34,036
Other creditors 158,349 213,688
226,188 263,211

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.1.24 31.1.23
£    £   
Bank loans - 5,788

9. LEASING AGREEMENTS
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

31.1.24 31.1.23
£    £   

199,949 279,949

Lillibet Healthcare Limited (Registered number: 09950456)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

10. SECURED DEBTS

The following secured debts are included within creditors:

31.1.24 31.1.23
£    £   
Bank loans 5,788 15,112

The bank loan is secured by a fixed and floating charge over the assets of the company.

11. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.24 31.1.23
value: £    £   
100 Ordinary shares £1 100 100

12. RELATED PARTY DISCLOSURES

Included within other debtors is an amount of £119,262 (2023: £193,939) owed by company in which the director has an interest.

Included within other creditors is an amount of £9,783 (2023: £37,000) owed to a company in which the director has an interest.

Included within other creditors is an amount of £79,259 (2023:£ 114,326) due to the director.

13. ULTIMATE CONTROLLING PARTY

The company is controlled by the director.